Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT04766502
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years old
* WHO 0 to 2
* Patient with cancer in the form of peritoneal carcinosmatois not eligible for cytoreduction surgery
* A histological diagnosis of the primary tumor or peritoneal carcinomatosis is essential.
* Patient with an indication for PIPAC for any reason (whether as part of a clinical research protocol or not). Patients with prior treatment with PIPAC are eligible.
* Patients with abdominal metastases or a single metastasis regardless of location (oligometastasis).
* For patients of childbearing age need for an effective method of contraception
* Informing patients and obtaining informed consent, dated and signed.
* Patient affiliated with a social security scheme
Exclusion Criteria:
* Age \< 18 years old
* WHO \> 3
* Patient who may benefit from cytoreduction surgery
* Patient with a contraindication to PIPAC
* Extra peritoneal disease with the exception of oligometastatic disease
* Persons deprived of liberty or under guardianship (including curatorship)
* Impossibility to undergo the medical follow-up of the trial for social, geographical or psychological reasons.
* For patients of childbearing age without an effective method of contraception
* Woman who is pregnant, likely to be pregnant, or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04766502
Study Brief:
Protocol Section:
NCT04766502